News|Articles|April 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-04-02-2004
  • Volume 28
  • Issue 4

Controlled-Release Dosage Forms for Diltiazem Hydrochloride

The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.

Articles in this issue

about 22 years ago

Spotlight on Business Risk

about 22 years ago

In the Spotlight April 2004

about 22 years ago

FDA Attacks Counterfeits

about 22 years ago

April 2004